Daniel Cook

Has grant

Assistant Professor

Iowa State University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Daniel Cook is an Assistant Professor at the University of Iowa, USA. His research focuses on the molecular mechanisms behind pulmonary arterial hypertension, ovarian cancer metastasis, and allergic inflammation. Recent publications highlight his work on the role of various cellular responses in disease states, particularly in cystic fibrosis and airway inflammation. He is dedicated to advancing the physician-scientist career path through mentorship and collaboration.

Recent Grants

Grant: Open

Inhibiting CD4+ Th2 development and function by CFTR activity.

Open Date: 2024-02-22

Close Date: 2029-01-31

Grant: Close

Role of Innate Lymphoid Cells in Cystic Fibrosis Airway Disease

Open Date: 2020-07-01

Close Date: 2026-06-01

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daniel Cook

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (13)

Paving the physician-scientist career path: from grassroots gathering to national forum

PGI2 restricts trained ILC2 responses in allergic inflammation

Mapping disease-specific vascular cell populations responsible for obliterative arterial remodeling during development of pulmonary arterial hypertension.

Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment.

PGI2 signaling metabolically reprograms CD4 Th2 cells and represses allergic airway inflammation.

CFTR negatively reprograms Th2 cell responses and CFTR potentiation restrains allergic airway inflammation

The Cystic Fibrosis Transmembrane Conductance Receptor Brakes Allergic Airway Inflammation

Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy

Cystic Fibrosis Reprograms Airway Epithelial IL-33 Release and Licenses IL-33–Dependent Inflammation

A Nod and a WNK (Kinase): Understanding Airway Surface Liquid pH

Clinical insights into pulmonary hypertension in chronic obstructive pulmonary disease.

Early lung disease exhibits bacteria-dependent and -independent abnormalities in cystic fibrosis pigs

Giant Hemangioma of the Mediastinum.

Collaborators (7)

Vern Kerchberger

Patrick Hu

Douglas Hornick

Bradley Richmond

Tiffany Scharschmidt

Mahmoud Abou Alaiwa

Thomas Gross

Make your next move.